Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Apr 18, 2011 · 10-K · 108 days after period end · 0001424884-11-000066
derived · Computed from the longer spans the company filed.
no prior Q4 2009 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2010 · filed Apr 18, 2011 · 108 d after period end
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
